In breast cancer, p21 is regarded as a protein with dual functions, as it is thought to be the chief mediator of p53-dependent cell cycle arrest caused by a stimulus, such as DNA damage, oncogene activation, and hypoxia [24]. Here, CDKN1A is linked to breast cancer.